Becker AM

Clinical Research Unit for Substance-Based Therapy, Department of Psychiatry (UPK), University of Basel, Wilhelm Klein-Strasse 27, 4002 Basel, Switzerland.

Becker AM

Psychedelics Restructure the Global Workspace of Consciousness

Low-dose lysergic acid diethylamide alters subjective visual perception but not visual contrast surround suppression.

LSD therapy: A few hundred meters from where it began.

Comparison of acute effects of 3,4-methylenedioxymethamphetamine (MDMA) with and without a supplemental booster dose in healthy participants: a double-blind, randomized, placebo-controlled, crossover study.

Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled Settings.

Neuroplastic white matter changes in patients with major depression following lysergic acid diethylamide treatment.

The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research.

Pharmacokinetics, Pharmacodynamics, and Urinary Recovery of Oral Mescaline Hydrochloride in Healthy Participants.

Efficacy and safety of low- versus high-dose-LSD-assisted therapy in patients with major depression: A randomized trial.

Motivation and retrospective appraisal of psychedelic study participation: a qualitative study in healthy volunteers.

Acute Effects and Pharmacokinetics of LSD after Paroxetine or Placebo Pre-Administration in a Randomized, Double-Blind, Cross-Over Phase I Trial.

Acute dose-dependent effects of mescaline in a double-blind placebo-controlled study in healthy subjects.

Pharmacological and non-pharmacological predictors of the LSD experience in healthy participants.

Safety pharmacology of acute psilocybin administration in healthy participants.

The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies.

Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants.

Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.

Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants.

Ketanserin Reverses the Acute Response to LSD in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Participants.

Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants.

Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects.

Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects.